HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder overhauls e-commerce site

This article was originally published in The Rose Sheet

Executive Summary

Firm's newly redesigned e-commerce Web site "tak[es] the guesswork out if shopping online," providing consumer with "a seamless experience from the Web site to the counter," according to Oct. 21 announcement. In addition to new "intuitive" product layout, site features company's Skincare Finder interactive diagnostic tool, which matches consumer with skin-care regimen tailored to her individual needs based on her responses to a series of questions. Online shoppers can also access Lauder's Foundation Finder, which identifies an ideal shade based on input related to skin intensity, undertone and type, as well as individual coverage preference; application tips from the pros also are provided, firm notes. Site additionally contains step-by-step instructional videos for achieving different makeup effects, such as smoky eyes, sculpted cheeks and classic lips. Personal profiles for Lauder spokesmodels - and their "current beauty must-haves" - are available as well. With more customers doing their shopping online, "we want to ensure [the consumer] is able to get the information and support she needs to make the best choices," says Elana Drell Szyfer, Estee Lauder's senior VP-global marketing

You may also be interested in...



Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Swisse Supplements Take Bigger Slice Of Chinese Market

Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel